Navigation Links
Eli Lilly and Company Aids California Recovery Effort

Company to provide up to $150,000 to relief agencies for recovery and

rebuilding effort

INDIANAPOLIS, Oct. 26 /PRNewswire-FirstCall/ -- Eli Lilly and Company (NYSE: LLY) today announced that it is responding to the devastating California fires with a commitment of up to $150,000 to relief agencies for the recovery and rebuilding efforts.

"Our hearts go out to everyone affected by these horrific fires," said John Lechleiter, president and chief operating officer. "We want to help those affected to recover and rebuild and hope that Lilly contributions might help in those efforts."

Lechleiter said that $100,000 in donations from the Lilly Foundation will be divided between three agencies. They are the San Diego chapter of the American Red Cross ($25,000) and the Salvation Army ($25,000 for immediate relief efforts, and the San Diego Foundation's "After the Fires" fund ($50,000), which will help support longer-term rebuilding efforts.

The Lilly Foundation also will match U.S. employee contributions, dollar for dollar, up to $50,000, which could bring the company's combined support to $200,000. Beginning today, any gift made by Lilly employees to any of the organizations noted above has been matched with company funds.

Nearly 40 Lilly employees -- most of them from the company's Applied Molecular Evolution research facility -- were among the nearly 1 million residents asked to evacuate from their homes. Fortunately, no Lilly employees have been injured as a result of the fires.

About Lilly

Lilly, a leading innovation-driven corporation, is developing a growing portfolio of first-in-class and best-in-class pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Ind., Lilly provides answers - through medicines and information -- for some of the world's most urgent medical needs. Additional information about Lilly is available at


SOURCE Eli Lilly and Company
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Animal insulin product to be discontinued by drug major Eli Lilly
2. Did Eli Lilly Turn Wily With Regard to Their Best-selling Schizophrenia Drug?
3. Eli Lilly Releases Digital Insulin Pen
4. Medicis Pharmaceutical company enters pediatric market
5. Problems Of a Growing Company
6. Teenagers Take More Risk-Taking Behaviors In The Company Of Same Sex Friends
7. British company developing ‘Safer Cigarettes
8. Australian Company Gets $10 million For Developing Skin Cancer Gel
9. Elderly People Prefer The Company Of Pet Dogs
10. Ossur Acquires the U.S. Orthopaedics Company
11. Britain Approves Indian Company For Supplying Medicines
Post Your Comments:
(Date:11/28/2015)... ... November 28, 2015 , ... Trying to relax on a couch can ... "I conceived of this design due to personal experience with a bad back," he ... relaxation and convenience, as well as increases support. It also makes it easier to ...
(Date:11/27/2015)... CA (PRWEB) , ... November 27, 2015 , ... According ... carried out by the University of Toronto and the University of British Columbia suggested ... hospitalizations for head injuries. The article explains that part of the reason for the ...
(Date:11/27/2015)... ... November 27, 2015 , ... "When ... said an inventor from Hillside, N.J. "Many people catch diseases simply from sitting ... individuals will always be protected from germs." , He developed the patent-pending QUDRATECS ...
(Date:11/27/2015)... ... 27, 2015 , ... Consistent with the Radiology Business ... Better Radiology Marketing Programs meeting will showcase some of the best 2015 ... Caesars Palace in Las Vegas with a pre-conference session on a collaborative approach ...
(Date:11/27/2015)... ... November 27, 2015 , ... CBD College is proud to ... Programs (CAAHEP) awarded accreditation to its Diagnostic Medical Sonography program. CBD College is honored ... one of twelve colleges and universities in the state of California make the cut. ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... 2015 ) ... "Radioimmunoassay Market by Type (Reagents & Kits, ... Clinical Diagnostic Labs), Application (Research, Clinical Diagnostics), ... report to their offering. --> ... of the "Radioimmunoassay Market by Type ...
(Date:11/25/2015)... 2015 ... "Global Brain Monitoring Devices Market 2015-2019" ... ) has announced the addition ... Market 2015-2019" report to their offering. ... ) has announced the addition of ...
(Date:11/25/2015)... 2015  Amgen (NASDAQ: AMGN ) today announced ... the United States (U.S.) Food ... candidate to Humira ® (adalimumab). Amgen believes this ... the FDA and represents Amgen,s first BLA submission using ... , M.D., executive vice president of Research and Development ...
Breaking Medicine Technology: